Description
Glycopyrrolate is an anticholinergic medication available as an injectable solution (0.2 mg/mL) for intramuscular or intravenous administration. It works by blocking certain nerve signals to reduce secretions and treat conditions like excessive salivation or slow heart rate. Marketed as a prescription drug under ANDA211334 by Sandoz. This information was generated using AI and is provided for informational and research purposes only.
Resources
| Name |
Format |
Description |
Link |
|
21 |
Access the FDA dataset for Glycopyrrolate — ANDA 211705 submitted by Mylan Institutional LLC
|
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211705 |
Tags
- drug-information
- health-care
- public-health
- prescription-drugs
- pharmaceuticals